Patents by Inventor Marko Pregel

Marko Pregel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel small molecules with selective cytotoxicity against human microvascular endothelial cell proliferation
    Publication number: 20070254894
    Abstract: Disclosed herein are angiogenesis inhibitors represented by formula (I) or formula (II): The variables for formulas (I) and (II) are defined herein.
    Type: Application
    Filed: January 9, 2007
    Publication date: November 1, 2007
    Inventors: John Kane, Bradford Hirth, Christopher Yee, Mark Staveski, Hans-Peter Biemann, Marko Pregel
  • Tetrahydroisoquinoline derivatives for treating protein trafficking diseases
    Publication number: 20050176761
    Abstract: Tetrhydroisoquinoline derivatives, pharmaceutical compositions comprising them and methods of treating disease are disclosed herein. The disclosed compounds are useful in the treatment and prevention of diseases mediated by chloride channel activity and/or protein trafficking, including, but not limited to, diseases associated with impaired mucociliary clearance such as cystic fibrosis, bronchitis, emphysema, and the like.
    Type: Application
    Filed: December 7, 2004
    Publication date: August 11, 2005
    Applicant: Genzyme Corporation
    Inventors: Marko Pregel, Bradford Hirth, John Kane, Shuang Qiao, Jill Gregory, Lisa Cuff